Trevi Therapeutics, Inc.TRVINASDAQ

Revenue (LTM)

Net Income (LTM)

$-43M

+10.8% YoY

Free Cash Flow

$-42M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.0B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	0	0	0
Gross Profit	0	0	0	0	-0
Operating Income	-32	-30↑7.9%	-34↓13.4%	-52↓51.9%	-49↑4.3%
Net Income	-34	-29↑14.1%	-29↑0.3%	-48↓64.8%	-43↑10.8%
EBITDA	-33	-28↑14.5%	-29↓2.1%	-48↓67.2%	-49↓3.2%
EPS Diluted	-1.49	-0.45↑69.8%	-0.29↑35.6%	-0.47↓62.1%	-0.29↑38.3%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	37	13↓65.8%	32↑157.3%	34↑5.2%	19↓44.5%
Total Current Assets	38	123↑223.0%	88↓28.6%	109↑25.0%	192↑75.1%
Total Assets	38	123↑219.7%	89↓27.3%	111↑24.0%	193↑74.4%
Total Current Liabilities	13	13↑5.3%	6↓56.5%	11↑80.4%	10↓7.2%
Total Liabilities	21	16↓27.3%	7↓55.9%	11↑64.2%	10↓9.4%
Total Equity	17	107↑529.3%	83↓23.2%	100↑20.7%	183↑83.9%
Total Debt	15	9↓37.3%	1↓85.4%	1↓22.9%	1↓27.0%
Net Debt	-22	-3↑84.6%	-31↓810.6%	-33↓6.5%	-18↑45.1%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-29	-28↑2.7%	-32↓12.5%	-38↓20.6%	-42↓10.0%
Capital Expenditure	0	-0	-0↑13.8%	-0↑74.5%	-0↑65.7%
Free Cash Flow	-29	-28↑2.1%	-32↓12.4%	-38↓20.2%	-42↓10.0%
Stock-Based Comp	3	2↓8.5%	2↓3.4%	4↑59.7%	5↑44.5%
Net Change in Cash	-8	-24↓196.7%	20↑181.7%	2↓91.4%	-15↓993.1%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance